/travel/countries/{country_code}/diseases

GET

/travel/countries/%7Bcountry_code%7D/diseases

GET

/travel/countries/%7Bcountry_code%7D/diseases

1 curl -G https://api.gideononline.com/travel/countries/%7Bcountry_code%7D/diseases \
2      -H "Authorization: <apiKey>" \
3      -d return=Optional \
4      -d search=Optional \
5      -d limit=Optional \
6      -d offset=Optional

200Travel_/travel/countries/{country_code}/diseases_example

1 {
2   "data": [
3     {
4       "icd9": [
5         "007.8"
6       ],
7       "icd10": [
8         "A07.8"
9       ],
10       "agents": [
11         {
12           "agent": "Parasite",
13           "agent_code": 1008
14         },
15         {
16           "agent": "Protozoan",
17           "agent_code": 1009
18         }
19       ],
20       "disease": "Blastocystis hominis infection",
21       "vectors": [
22         {
23           "vector": "None",
24           "vector_code": "N"
25         }
26       ],
27       "synonyms": [
28         "Apoi",
29         "Blastocystiose",
30         "Blastocystis hominis",
31         "Zierdt-Garavelli disease"
32       ],
33       "vaccines": [],
34       "vehicles": [
35         {
36           "vehicle": "Fecal-oral (human)",
37           "vehicle_code": "FE"
38         },
39         {
40           "vehicle": "Food",
41           "vehicle_code": "F"
42         },
43         {
44           "vehicle": "Water",
45           "vehicle_code": "W"
46         }
47       ],
48       "pathogens": [
49         {
50           "pathogen": "Blastocystis hominis",
51           "is_drug_class": "N",
52           "pathogen_code": 145
53         }
54       ],
55       "agent_text": "PARASITE - Protozoa. \r\nChromista, Bigyra, Blastocystea:\r\n<i>Blastocystis hominis</i>. \r\n(taxonomic status remains uncertain)",
56       "incubation": "Unknown",
57       "reservoirs": [
58         {
59           "reservoir": "Human",
60           "reservoir_code": "M"
61         }
62       ],
63       "adult_drugs": [
64         {
65           "drug": "Trimethoprim",
66           "disease_code": 10200
67         },
68         {
69           "drug": "Tinidazole",
70           "disease_code": 10200
71         },
72         {
73           "drug": "Sulfamethoxazole / Trimethoprim",
74           "disease_code": 10200
75         },
76         {
77           "drug": "Nitazoxanide",
78           "disease_code": 10200
79         },
80         {
81           "drug": "Metronidazole",
82           "disease_code": 10200
83         }
84       ],
85       "vector_text": "None",
86       "disease_code": 10200,
87       "vehicle_text": "Fecal-oral, Water",
88       "adult_therapy": "No treatment necessary for asymptomatic patients\r\n\r\nNitazoxanide 500 mg BID X 3 d. \r\nOR Metronidazole 750 mg TID X 10d. \r\nOR Tinidazole 2 G Once \r\nOR Sulfamethoxazole / Trimethoprim",
89       "clinical_note": "Symptoms ascribed to blastocystosis include leucocyte-negative diarrhea, nausea, pain {p 16863863} , flatulence and abdominal distention. {p 11586558} {p 2023289} \r\n - Some reports suggest an association between urticaria and <i>Blastocystis</i> infection. {p 23360793} {p 20922413} {p 18176765} {p 16637808} {p 16191864} {p 15368795} {p 8237719} {p 21790724} {p 24553977}\r\n - Symptoms usually last for 3 to 10 days, but may persist for weeks or months.  \r\n - <i>Blastocystis hominis</i> has also been implicated in the etiology of irritable bowel syndrome {p 18854485} {p 21870243} {p 28668983} , and may contribute to the development of anemia among infected pregnant women. {p 22167376}\r\n - A case of presumed <i>Blastocystis</i> appendicitis with peritonitis has been reported. {p 25528951}\r\n\r\nA search for alternative etiologies (including other infectious agents) should always be made in such patients. {p 8894352} {p 18629417}",
90       "clinical_hints": "The precise role of this organism in disease is controversial\r\n - Diarrhea and flatulence, usually without fever\r\n - The illness is similar to giardiasis\r\n - Increased risk among immune-suppressed patients",
91       "reservoir_text": "Human",
92       "pediatric_drugs": [
93         {
94           "drug": "Trimethoprim",
95           "disease_code": 10200
96         },
97         {
98           "drug": "Tinidazole",
99           "disease_code": 10200
100         },
101         {
102           "drug": "Sulfamethoxazole / Trimethoprim",
103           "disease_code": 10200
104         },
105         {
106           "drug": "Nitazoxanide",
107           "disease_code": 10200
108         },
109         {
110           "drug": "Metronidazole",
111           "disease_code": 10200
112         }
113       ],
114       "diagnostic_tests": "Stool microscopy.\r\nNucleic acid amplification.",
115       "pediatric_therapy": "No treatment necessary for asymptomatic patients \r\n\r\nNitazoxanide - \r\nAge 1 to 3 years: 5 ml (100 mg) PO Q12h X 3 days\r\nAge 4 to 11 years: 10 mg (200 mg) PO Q12h X 3 days; \r\nOR Metronidazole 15 mg/kg/d X 10d. \r\nOR Tinidazole (age >3) 50 mg/kg Once \r\nOR Sulfamethoxazole / Trimethoprim",
116       "therapy_references": [
117         {
118           "href": "/references/p/12650658",
119           "citation": "J Travel Med 2003 Mar-Apr;10(2):128-30.",
120           "short_citation": "",
121           "reference_number": "p 12650658"
122         },
123         {
124           "href": "/references/p/10566723",
125           "citation": "Am J Gastroenterol 1999 Nov ;94(11):3245-7.",
126           "short_citation": "",
127           "reference_number": "p 10566723"
128         },
129         {
130           "href": "/references/p/16234044",
131           "citation": "Clin Gastroenterol Hepatol 2005 Oct ;3(10):987-91.",
132           "short_citation": "",
133           "reference_number": "p 16234044"
134         }
135       ],
136       "clinical_references": [
137         {
138           "href": "/references/p/16863863",
139           "citation": "J Pediatr Surg 2006 Aug ;41(8):1489-91.",
140           "short_citation": "",
141           "reference_number": "p 16863863"
142         },
143         {
144           "href": "/references/p/11586558",
145           "citation": "Gastroenterol Clin North Am 2001 Sep ;30(3):797-815, x.",
146           "short_citation": "",
147           "reference_number": "p 11586558"
148         },
149         {
150           "href": "/references/p/2023289",
151           "citation": "J Trop Med Hyg 1991 Apr ;94(2):118-22.",
152           "short_citation": "",
153           "reference_number": "p 2023289"
154         },
155         {
156           "href": "/references/p/23360793",
157           "citation": "Am J Med Sci 2013 Jul ;346(1):80-1.",
158           "short_citation": "",
159           "reference_number": "p 23360793"
160         },
161         {
162           "href": "/references/p/20922413",
163           "citation": "Parasitol Res 2011 Mar ;108(3):553-60.",
164           "short_citation": "",
165           "reference_number": "p 20922413"
166         },
167         {
168           "href": "/references/p/18176765",
169           "citation": "Acta Derm Venereol 2008  ;88(1):80-1.",
170           "short_citation": "",
171           "reference_number": "p 18176765"
172         },
173         {
174           "href": "/references/p/16637808",
175           "citation": "Australas J Dermatol 2006 May ;47(2):117-9.",
176           "short_citation": "",
177           "reference_number": "p 16637808"
178         },
179         {
180           "href": "/references/p/16191864",
181           "citation": "Acta Derm Venereol 2005  ;85(4):357-8.",
182           "short_citation": "",
183           "reference_number": "p 16191864"
184         },
185         {
186           "href": "/references/p/15368795",
187           "citation": "Eur Rev Med Pharmacol Sci 2004 May-Jun;8(3):117-20.",
188           "short_citation": "",
189           "reference_number": "p 15368795"
190         },
191         {
192           "href": "/references/p/8237719",
193           "citation": "Allergol Immunopathol (Madr) 1993 Jul-Aug;21(4):149-51.",
194           "short_citation": "",
195           "reference_number": "p 8237719"
196         },
197         {
198           "href": "/references/p/21790724",
199           "citation": "Clin Exp Dermatol 2011 Dec ;36(8):908-10.",
200           "short_citation": "",
201           "reference_number": "p 21790724"
202         },
203         {
204           "href": "/references/p/24553977",
205           "citation": "Parasitol Res 2014 Apr ;113(4):1585-90.",
206           "short_citation": "",
207           "reference_number": "p 24553977"
208         },
209         {
210           "href": "/references/p/18854485",
211           "citation": "Clin Microbiol Rev 2008 Oct ;21(4):639-65.",
212           "short_citation": "",
213           "reference_number": "p 18854485"
214         },
215         {
216           "href": "/references/p/21870243",
217           "citation": "Parasitol Res 2012 Mar ;110(3):1269-75.",
218           "short_citation": "",
219           "reference_number": "p 21870243"
220         },
221         {
222           "href": "/references/p/28668983",
223           "citation": "Parasitol Res 2017 Sep ;116(9):2361-2371.",
224           "short_citation": "",
225           "reference_number": "p 28668983"
226         },
227         {
228           "href": "/references/p/22167376",
229           "citation": "Parasitol Res 2012 Jun ;110(6):2167-74.",
230           "short_citation": "",
231           "reference_number": "p 22167376"
232         },
233         {
234           "href": "/references/p/25528951",
235           "citation": "Emerg Infect Dis 2015 Jan ;21(1):91-4.",
236           "short_citation": "",
237           "reference_number": "p 25528951"
238         },
239         {
240           "href": "/references/p/8894352",
241           "citation": "Clin Microbiol Rev 1996 Oct ;9(4):563-84.",
242           "short_citation": "",
243           "reference_number": "p 8894352"
244         },
245         {
246           "href": "/references/p/18629417",
247           "citation": "J Microbiol Immunol Infect 2008 Jun ;41(3):222-6.",
248           "short_citation": "",
249           "reference_number": "p 18629417"
250         }
251       ]
252     }
253   ],
254   "limit": 10,
255   "total": 13,
256   "offset": 5
257 }

Returns the list of relevant diseases for travelers to the selected country.

Authentication

Authorizationstring

API Key authentication via header

Query parameters

returnstringOptional

detailed | simple (default)

searchstringOptional

String. prefix search

limitstringOptional

Numeric. Specifies records per page

offsetstringOptional

Numeric. Specifies the starting record

Response headers

X-Frame-Optionsstring

X-XSS-Protectionstring

X-Content-Type-Optionsstring

Strict-Transport-Securitystring

Response

datalist of objects

limitinteger

totalinteger

offsetinteger